Am Ag:PrThr:Pt:RBC:Ord

Known as: Am Ag:MevcE?ik:Zml?:Eritrosit:Srl, Am , Ag:Présence-Seuil:Temps ponctuel:GR:Ordinal, Am ??:????:????:???:???? 
 
National Institutes of Health

Related topics

Related topics

3 relations
AM antigenAntigensErythrocytes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.
AIMS This open-label, two-period, randomized, crossover study was designed to determine the effect of CYP2C19 reduced function… (More)
Is this relevant?
2012
2012
Relationship between exposure to prasugrel active metabolite and clinical outcomes in the TRITON-TIMI 38 substudy.
In TRITON-TIMI 38, levels of the prasugrel active metabolite (pras-AM) were measured in a population pharmacokinetic substudy… (More)
Is this relevant?
Review
2010
Review
2010
Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrel.
Thienopyridines are inactive prodrugs that are converted in vivo to active metabolites, which irreversibly bind to and inactivate… (More)
Is this relevant?
2009
2009
Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38.
Serial pharmacokinetic (PK) sampling in 1159 patients from TRITON-TIMI 38 was undertaken. A multilinear regression model was used… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?
2008
2008
Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease
The aim of the current analysis was to characterize the population PK of prasugrel and clopidogrel metabolites, the resulting PD… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2006
2006
N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Breast cancer most frequently metastasizes to bone causing decreased quality of life and morbidity. Since current treatments are… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrate.
Resistance to anticancer drugs has been attributed to an array of cellular changes. The multidrug resistance-related protein… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Selenate and selenite sorption on iron oxides: an infrared and electrophoretic study.
We studied selenate and selenite sorption by amorphous Fe oxide [am-Fe(OH)3] and goethite (a-FeOOH) as a function of time (25 min… (More)
Is this relevant?
2000
2000
Calcein-AM is a detector of intracellular oxidative activity
Calcein-acetoxymethylester (calcein-AM) is a non-fluorescent, cell permeant compound, which is converted by intracellular… (More)
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
1993
Highly Cited
1993
A new microcellular cytotoxicity test based on calcein AM release.
We present a microtest for cell-mediated immunity, based on the use of the Tarasaki tray and calcein AM vital dye. The number of… (More)
Is this relevant?